بررسی مقایسه‌ای اثر قرص زنجبیل با اندانسترون در تهوع و استفراغ بارداری: یک کارآزمایی بالینی

نوع مقاله : اصیل پژوهشی

نویسندگان

1 کارشناس ارشد مامایی، مرکز تحقیقات یائسگی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی جندی‌ شاپور اهواز، اهواز، ایران.

2 کارشناس ارشد مامایی، مرکز تحقیقات ارتقای سلامت باروری، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی جندی ‌شاپور اهواز، اهواز، ایران.

3 دکترای تغذیه جامعه، مرکز تحقیقات یائسگی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی جندی‌ شاپور اهواز، اهواز، ایران.

4 کارشناس ارشد آمار زیستی، دانشکده بهداشت، دانشگاه علوم پزشکی جندی‌ شاپور اهواز، اهواز، ایران.

چکیده

مقدمه: تهوع و استفراغ، از شایع ­ترین عوارض دوران بارداری است. جهت به حداقل رساندن مصرف داروهای شیمیایی در زنان باردار و پیشگیری از اثرات جانبی آنها، مطالعه حاضر با هدف مقایسه تأثیر قرص زنجبیل با اندانسترون در درمان تهوع و استفراغ بارداری انجام شد.
روشکار: این مطالعه کارآزمایی بالینی دوسوکور در سال 1397 بر روی 110 زن باردار دارای تهوع و استفراغ در هفته‌های ۱۵-10 بارداری که به درمانگاه‌های بهداشت خانواده بندر ماهشهر مراجعه نمودند، انجام شد. زنان به‌طور تصادفی در دو گروه 55 نفره زنجبیل و اندانسترون قرار گرفتند. گروه زنجبیل، 9 قرص 500 میلی‌گرمی، تشکیل شده از پودر خشک زنجبیل را به‌مدت 3 ‌روز و گروه اندانسترون، 9 قرص 4 میلی‌گرمی اندانسترون را به‌مدت 3 ‌روز استفاده کردند. ابزار گردآوری اطلاعات شامل پرسشنامه دموگرافیک و پرسشنامه شاخص رودز بود که قبل از ورود به مداخله و نیز هر روز 2 بار در جریان مطالعه، شدت و دفعات تهوع و استفراغ مورد ارزیابی قرار می­گرفت. تجزیه و تحلیل داده‌ها با استفاده از نرم‌افزار آماری SPSS­ (نسخه 22) و آزمون‌های من‌ویتنی، ویلکاکسون، تی مستقل انجام شد. میزان p کمتر از 05/0 معنی‌دار در نظر گرفته شد.
یافته ها: میانگین نمره کل شاخص رودز در گروه زنجبیل از 7/3±61/12 به 23/6±43/5 و در گروه اندانسترون از 73/4±5/14 به 86/3±89/3 کاهش یافت (001/0>p)، در نتیجه زنجبیل به اندازه اندانسترون در کاهش دفعات و شدت تهوع و استفراغ بارداری مؤثر بود.
نتیجه­ گیری: زنجبیل و اندانسترون هر دو در درمان تهوع و استفراغ بارداری مؤثر هستند و تأثیر زنجبیل و اندانسترون با اختلاف بسیار اندک یکسان می‌باشد.

کلیدواژه‌ها


عنوان مقاله [English]

Comparison of the Effects of Ondansetron and Ginger on Nausea and Vomiting in Pregnancy: A Clinical Trial

نویسندگان [English]

  • Mitra Tadayon najafabadi 1
  • Zahra Khalili Moghadam 2
  • Parvin Abedi 3
  • Mohammad Hosein Haghighizadeh 4
1 M.Sc. in Midwifery, Menopause Andropause Research Center, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
2 M.Sc.in Midwifery, Reproductive Health Promotion Research Center, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
3 PhD in Community Nutrition, Menopause Andropause Research Center, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
4 M.Sc. in Biostatistics, School of public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
چکیده [English]

Introduction: Nausea and vomiting are the most common complications of pregnancy. In order to minimize the consumption of chemical drugs and prevent their side effects in pregnant women, this study was conducted with aim to compare the effect of Ondansetron versus Ginger on nausea and vomiting in pregnancy.        
Methods: This double-blind clinical trial study was conducted in 2018 on 110 pregnant women with nausea and vomiting in 10-15 weeks of pregnancy who referred to health family clinics of Bandar Mahshahr. Women were randomly assigned to two groups of ginger (n=55) and ondansetron (n=55). The ginger group used 9 tablets of 500 mg consisting of dry ginger powder for three days (once every 8 hours) and the ondansetron group used 9 tablets of 4 mg ondansetron for three days (once every 8 hours). Data collection tool included a demographic questionnaire and a Rhodes index questionnaire which assessed the severity and frequency of nausea and vomiting before entering the intervention and twice a day during the study. Data were analyzed by SPSS software (version 22(, using Mann-Whitney, Wilcoxon, and independent t tests. P<0.05 was considered statistically significant.
Results: The mean score of the Rhodes index in the ginger group decreased from 12.61 ± 3.7 to 5.43 ± 6.23 and in the ondansetron group from 14.5 ± 4.73 to 3.89 ± 3.86 (p<0.001). Therefore, ginger was as effective as ondansetron in reducing the frequency and severity of nausea and vomiting during pregnancy.
Conclusion: Both ginger and ondansetron are effective in treating nausea and vomiting of pregnancy and the effect of ginger and ondansetron is the same with a very small difference.

کلیدواژه‌ها [English]

  • Ginger
  • Nausea and vomiting
  • Ondansetron
  • Pregnancy
  1. Li P, Wang H, Chen G, Feng J, Fan D, Lin D, et al. Association between nausea and vomiting during pregnancy and sleep quality: mediating effect of depressive symptoms. International journal of general medicine 2021: 41-9.
  2. Fejzo MS, Trovik J, Grooten IJ, Sridharan K, Roseboom TJ, Vikanes Å, et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nature reviews Disease primers 2019; 5(1):62.
  3. Herrell HE. Nausea and vomiting of pregnancy. American family physician. 2014 Jun 15; 89(12):965-70.
  4. Colodro-Conde L, Cross SM, Lind PA, Painter JN, Gunst A, Jern P, et al. Cohort Profile: Nausea and vomiting during pregnancy genetics consortium (NVP Genetics Consortium). International journal of epidemiology 2017; 46(2):e17.
  5. Bray N, Grasby KL, Lind PA, Painter JN, Colodro-Conde L, Medland SE. The psychosocial impact of nausea and vomiting during pregnancy as a predictor of postpartum depression. Journal of health psychology 2021; 26(7):1061-72.
  6. Schrager NL, Adrien N, Werler MM, Parker SE, Van Bennekom C, Mitchell AA, et al. Trends in first‐trimester nausea and vomiting of pregnancy and use of select treatments: Findings from the National Birth Defects Prevention Study. Paediatric and perinatal epidemiology 2021; 35(1):57-64.
  7. Willetts KE, Ekangaki A, Eden JA. Effect of a ginger extract on pregnancy‐induced nausea: A randomised controlled trial. Australian and New Zealand journal of obstetrics and gynaecology 2003; 43(2):139-44.
  8. Viljoen E, Visser J, Koen N, Musekiwa A. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutrition journal 2014; 13:1-4.
  9. Zhang M, Zhao R, Wang D, Wang L, Zhang Q, Wei S, et al. Ginger (Zingiber officinale Rosc.) and its bioactive components are potential resources for health beneficial agents. Phytotherapy Research 2021; 35(2):711-42.
  10. Hollyer T, Boon H, Georgousis A, Smith M, Einarson A. The use of CAM by women suffering from nausea and vomiting during pregnancy. BMC complementary and alternative medicine 2002; 2(1):1-6.
  11. Nievergelt A, Huonker P, Schoop R, Altmann KH, Gertsch J. Identification of serotonin 5-HT1A receptor partial agonists in ginger. Bioorganic & medicinal chemistry 2010; 18(9):3345-51.
  12. Sakran R, Shechtman S, Arnon J, Diav-Citrin O. Pregnancy outcome following in-utero exposure to ondansetron: A prospective comparative observational study. Reproductive Toxicology 2021; 99:9-14.
  13. Koren G. Is ondansetron safe for use during pregnancy?. Canadian Family Physician 2012; 58(10):1092-3.
  14. Rojas C, Slusher BS. Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting. European journal of pharmacology 2012; 684(1-3):1-7.
  15. Oliveira LG, Capp SM, You WB, Riffenburgh RH, Carstairs SD. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial. Obstetrics & Gynecology 2014; 124(4):735-42.
  16. Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food and chemical Toxicology 2008; 46(2):409-20.
  17. Jamigorn M, Phupong V. Acupressure and vitamin B6 to relieve nausea and vomiting in pregnancy: a randomized study. Archives of gynecology and obstetrics 2007; 276:245-9.
  18. Refuerzo JS, Smith JA, Ramin SM. Clinical features and evaluation of nausea and vomiting of pregnancy. Uptodate Clin Features 2013; 2012:26.
  19. Abol Ghasemi S, Razmjoo N, Moallem A, Esmaeili H. Efficacy of Ginger capsule on nausea and vomiting during pregnancy. Journal of Babol University of Medical Sciences 2004; 6(3):17-20.
  20. Vutyavanich T, Kraisarin T, Ruangsri RA. Ginger for nausea and vomiting in pregnancy:: Randomized, double-masked, placebo-controlled trial. Obstetrics & Gynecology 2001; 97(4):577-82.
  21. Ben-Aroya Z, Lurie S, Segal D, Hallak M, Glezerman M. Association of nausea and vomiting in pregnancy with lower body mass index. European Journal of Obstetrics & Gynecology and Reproductive Biology 2005; 118(2):196-8.
  22. Chan RL, Olshan AF, Savitz DA, Herring AH, Daniels JL, Peterson HB, et al. Maternal influences on nausea and vomiting in early pregnancy. Maternal and child health journal 2011; 15:122-7.
  23. Barat S, Bouzari Z, Lakae Andy F. Factors Affecting the Severity of Nausea and Vomiting in Women's Pregnant Attending Prenatal Clinics Rouhani Hospital, Babol. Journal of Jiroft University of Medical Sciences 2015; 2(1):106-15.
  24. Faramarzi M, Ranjbar TA, Zakariaii Z, Naeimirad M. Role of psycho-social factors in pregnant women with nausea and vomiting. Daneshvar 2015; 23(119):73-80.
  25. Fischer-Rasmussen W, Kjær SK, Dahl C, Asping U. Ginger treatment of hyperemesis gravidarum. European Journal of Obstetrics & Gynecology and Reproductive Biology 1991; 38(1):19-24.
  26. Suarez EA, Boggess K, Engel SM, Stürmer T, Lund JL, Funk MJ. Ondansetron use in early pregnancy and the risk of late pregnancy outcomes. Pharmacoepidemiology and Drug Safety 2021; 30(2):114-25.
  27. Jamilian M. Comparison of the Effect of Ginger, Gabapentin, and Ondansetron for Prevention of Nausea and Vomiting After Cesarean Section by Spinal Anesthesia. cmja 2015; 5(2):1123-32.
  28. Mandal P, Das A, Majumdar S, Bhattacharyya T, Mitra T, Kundu R. The efficacy of ginger added to ondansetron for preventing postoperative nausea and vomiting in ambulatory surgery. Pharmacognosy research 2014; 6(1):52.